SEC Form D · filed July 31, 2020
NovaBay Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Swan E. Sit · EMERYVILLE, CADirectorYenyou (Jeff) E. Zheng · EMERYVILLE, CADirectorMijia (Bob) E. Wu · EMERYVILLE, CADirectorJustin M. Hall · EMERYVILLE, CAExecAndrew M. Jones · EMERYVILLE, CAExecPaul E. Freiman · EMERYVILLE, CADirectorXiaopei (Ray) Wang · EMERYVILLE, CADirectorXinzhou (Paul) E. Li · EMERYVILLE, CADirectorJp A. Paquin · New York, NYDirectorCato Partners GP, LLC · New York, NYDirectorBrook Katzen · Chilmark, MADirectorSean Stiefel · Redondo Beach, CAExecWilliam Burns · McKinney, TXExecCato Partners Management, LLC · New York, NYDirectorMatt Forti · Highland Park, ILDirectorSamuel Schreiber · Chilmark, MADirectorDavid Irwin · Bellevue, WADirectorSteven M. Diedrich · Waco, TXDirectorBrian Moreland · Bronx, NYDirectorJerry L. Whitmire · Tempe, AZDirectorvan Biema Value Partners, LLC · New York, NYDirectorvan Biema & Company, LLC · New York, NYExecJeff Siegel · Huntsville, UTExecStephen Dalby · Lehi, UTDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗